Amgen (AMGN) Dividend Coverage Ratio (QoQ) (2011 - 2026)
Powered by 
Analysis
Amgen (AMGN) Dividend Coverage Ratio (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn |
| 10 | Insmed | 28.20 Bn | 27.04 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.18% |
| Mar 31, 2026 | 28.92% |
| Dec 31, 2025 | -58.58% |
| Sep 30, 2025 | 124.23% |
| Jun 30, 2025 | -17.29% |
| Mar 31, 2025 | 159.95% |
| Dec 31, 2024 | -77.75% |
| Sep 30, 2024 | 279.04% |
| Jun 30, 2024 | 759.63% |
| Mar 31, 2024 | -113.90% |
| Dec 31, 2023 | -55.66% |
| Sep 30, 2023 | 25.34% |
| Jun 30, 2023 | -51.55% |
| Mar 31, 2023 | 60.81% |
| Dec 31, 2022 | -24.74% |
| Sep 30, 2022 | 62.72% |
| Jun 30, 2022 | -7.16% |
| Mar 31, 2022 | -28.75% |
| Dec 31, 2021 | 1.71% |
| Sep 30, 2021 | 309.69% |